½ÃÀ庸°í¼­
»óǰÄÚµå
1587708

¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå ¿¹Ãø : µð¹ÙÀ̽º À¯Çüº°, ÃøÁ¤ ¹æ¹ýº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº° ºÐ¼®(-2030³â)

Body Temperature Monitoring Market Forecasts to 2030 - Global Analysis By Device Type (Wearable Devices and Non-Wearable Devices), Measurement Method (Contact-based and Non-contact), Technology, End User, Distribution Channel and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀåÀº 2024³â¿¡ 17¾ï ´Þ·¯·Î ÃßÁ¤µÇ°í, 2030³â¿¡´Â 24¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 6.3%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

»ç¶÷ÀÇ Ã¼¿ÂÀ» ÃøÁ¤Çϰí À̸¦ ÃßÀûÇÏ¿© ¹ß¿­À̳ª Àúü¿Â°ú °°Àº °Ç°­ ¹®Á¦¸¦ °¡¸®Å³ ¼ö ÀÖ´Â ÀÌ»óÀ» È®ÀÎÇÏ´Â °úÁ¤Àº ü¿Â ¸ð´ÏÅ͸µÀ¸·Î ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù. Á¶±â °¨¿°Áõ Áø´Ü°ú ¸¸¼ºÁúȯÀÇ ¸ð´ÏÅ͸µÀÌ °¡´ÉÇϱ⠶§¹®¿¡ ÇコÄɾ´Â ºü¶ß¸± ¼ö ¾ø´Â ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù. ü¿Â°è´Â °¡Á¤, ½ºÆ÷Ã÷, º´¿ø µî ´Ù¾çÇÑ Àå¸é¿¡¼­ »ç¿ëµË´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú °³¹ßÀÇ °á°ú·Î, ü¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº º¸´Ù Á¤È®ÇÏ°í ½Ç¿ëÀûÀÌ¸ç ½Ç½Ã°£ÀÔ´Ï´Ù.

¹Ì±¹ Áúº´ ¿¹¹æ°ü¸®¼¾ÅÍ(CDC)¿¡ µû¸£¸é 2022-2023³â ¹Ì±¹ÀÇ ÀÎÇ÷翣ÀÚ ½ÃÁð¿¡´Â ÃßÁ¤ 2,700¸¸-5,400¸¸ ¸íÀÇ ÀÎÇ÷翣ÀÚ È¯ÀÚ°¡ ¹ß»ýÇß½À´Ï´Ù.

°¨¿°ÀÇ À¯Çà È®´ë

ÀÎÇ÷翣ÀÚ, COVID-19 ¹× ±âŸ ¹ÙÀÌ·¯½º °¨¿°°ú °°Àº °¨¿°ÀÇ À¯ÇàÀÌ Áõ°¡ÇÏ´Â °ÍÀº ü¿Â ¸ð´ÏÅ͸µ Àåºñ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹ß¿­Àº ¸¹Àº °¨¿°¿¡ °øÅëµÈ Áõ»óÀÔ´Ï´Ù. Á¤È®ÇÑ Ã¼¿Â ÃøÁ¤Àº Áúº´ÀÇ Á¶±â ¹ß°ß°ú ÁøÇà ¸ð´ÏÅ͸µ¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÀ¯·Î °Ç°­ °ü¸® ȯ°æ, °ø°ø Àå¼Ò ¹× °¡Á¤¿¡¼­ÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Áúº´ ¹ß»ý ½Ã Áö¼ÓÀûÀÎ ¿Âµµ ÃßÀûÀÇ Çʿ伺Àº ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­ÇÏ°í ¿þ¾î·¯ºí ¹× ºñÁ¢ÃË ¿Âµµ ¸ð´ÏÅ͸µ ±â¼úÀÇ Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºíÀÇ Á¤¹Ðµµ ¿ì·Á

¿þ¾î·¯ºí ±â¼úÀº Æí¸®¼º°ú Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇÏ´Â ÇÑÆí, ±× Á¤¹Ðµµ´Â ȯ°æ Á¶°Ç, ÇǺΠÁ¢ÃË, °³ÀÎÀÇ »ý¸®Àû º¯µ¿ µîÀÇ ¿äÀο¡ ÀÇÇØ ¿µÇâÀ» ¹ÞÀ» °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ü¿Â ÃøÁ¤Ä¡¿¡ Àϰü¼ºÀÌ ¾ø°Å³ª ½Å·Ú¼ºÀÌ ³·À» ¼ö ÀÖÀ¸¸ç, ÀÓ»ó»ó ÀÇ»ç °áÁ¤À̳ª ȯÀÚ Äɾ ¼Õ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÇコÄɾî Àü¹®°¡³ª ¼ÒºñÀÚµéÀº ¿þ¾î·¯ºí ü¿Â°è¿¡ ÀüÀûÀ¸·Î ÀÇÁ¸ÇÏ´Â °ÍÀ» ÁÖÀúÇϰí Áß¿äÇÑ Ã¼¿Â Æò°¡¿¡´Â ÀüÅëÀûÀÎ ¹æ¹ýÀ» ¼±È£ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¿¹¹æ ÀÇ·á Á߽à Áõ°¡

°³ÀÎÀÇ °Ç°­ ÀǽÄÀÌ ³ô¾ÆÁ®, °Ç°­ °ü¸®¿¡ Àû±ØÀûÀ¸·Î ³ª¼­°í ÀÖ½À´Ï´Ù. ÀÌ ¶§¹®¿¡ ü¿Â ¼¾¼­¸¦ Æ÷ÇÔÇÑ °³ÀÎ¿ë °Ç°­ ¸ð´ÏÅ͸µ ±â±â ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ½º¸¶Æ®¿öÄ¡³ª ÇÇÆ®´Ï½º Æ®·¡Ä¿¿¡ ü¿Â ¸ð´ÏÅ͸µ ±â´ÉÀÌ ÅëÇÕµÇ¾î ¼ÒºñÀÚ°¡ Á¤±âÀûÀ¸·Î ü¿ÂÀ» ÃßÀûÇϱ⠽¬¿öÁö¸é¼­ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÇコÄɾî ÇÁ·Î¹ÙÀÌ´õ´Â Áúº´ÀÇ Á¶±â ¹ß°ß°ú ¿¹¹æÀ» Á¡Á¡ Áß½ÃÇÏ°Ô µÇ°í ÀÖÀ¸¸ç, ȯÀÚÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú Á¶±â °³ÀÔÀ» À§ÇØ ÀÓ»ó ÇöÀå¿¡¼­ÀÇ °íµµÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã

ÀÌ·¯ÇÑ ¸ð´ÏÅ͸µ Àåºñ´Â °³ÀÎÀÇ Ã¼¿Â°ú ÀáÀçÀûÀ¸·Î ´Ù¸¥ °Ç°­ ÁöÇ¥¿¡ ´ëÇÑ ¹Î°¨ÇÑ Á¤º¸¸¦ ¼öÁýÇÕ´Ï´Ù. µ¥ÀÌÅÍÀÇ ¾ÈÀü¼º, ºÎÁ¤ ¾×¼¼½º, ÀÌ Á¤º¸ÀÇ ¾Ç¿ë °¡´É¼º¿¡ °üÇÑ ¿ì·Á°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ µ¥ÀÌÅÍ º¸È£ ±ÔÁ¦¿Í °ß°íÇÑ »çÀ̹ö º¸¾È ´ëÃ¥ÀÇ Çʿ伺À¸·Î ÀÎÇØ Á¦Á¶¾÷ü´Â °³¹ß ºñ¿ë°ú º¹À⼺ÀÌ ³ô¾ÆÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ºÒ¾ÈÀº ƯÈ÷ ºñÀÓ»ó ȯ°æ¿¡¼­ °íµµÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀ» ¹æÇØÇØ ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

COVID-19 ÆÒµ¥¹ÍÀº ü¿Â ¸ð´ÏÅ͸µ ½ÃÀåÀ» Å©°Ô ¹Ð¾î ¿Ã·È½À´Ï´Ù. ÇコÄÉ¾î ½Ã¼³, Á÷Àå, °ø°ø °ø°£¿¡¼­ ÀáÀçÀûÀÎ °¨¿°ÁõÀ» °ËÃâÇϱâ À§ÇØ ±¤¹üÀ§ÇÑ Ã¼¿Â ½ºÅ©¸®´×ÀÌ Çʼö°¡ µÇ½À´Ï´Ù. ÀÌ ¶§¹®¿¡, ºñÁ¢ÃË½Ä Ã¼¿Â°è¿Í Àû¿Ü¼± ¿µ»ó ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çß½À´Ï´Ù. ÆÒµ¥¹ÍÀº ¶Ç, ¿þ¾î·¯ºí ü¿Â ¸ð´ÏÅ͸µ ±â±â³ª ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ ±â¼ú Çõ½ÅÀ» °¡¼Ó½ÃÄÑ, ½ÃÀå µ¿ÇâÀ̳ª ¼ÒºñÀÚÀÇ ±âÈ£¸¦ À籸ÃàÇß½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Á¢ÃË ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ °ÍÀ¸·Î ¿¹»ó

Á¢ÃËÇü ºÎ¹®Àº ¿¹Ãø ±â°£À» ÅëÇØ ÃÖ´ë ½ÃÀå Á¡À¯À²À» È®º¸ÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ ¿ìÀ§¼ºÀº Á¢ÃË½Ä Ã¼¿Â°èÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀÌ ÀνĵǾî ÇコÄɾî ȯ°æÀ̳ª °¡Á¤¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ´Â °Í¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. Á¢ÃË½Ä Ã¼¿Â°è´Â ÀÓ»ó Áø´Ü°ú ȯÀÚ °ü¸®¿¡¼­ ±× Á¤È®¼ºÀ» ¼±È£ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âÁ¸ÀÇ ¹æ¹ý¿¡ ´ëÇÑ Ä£¼÷ÇÔ°ú ½Å·Ú´Â ºñ¿ë ´ëºñ È¿°ú¿Í »ç¿ë ÆíÀǼº°ú ¸Â¹°·Á Áö¼ÓÀûÀÎ Àα⿡ ±â¿©ÇÏ°í ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ È®°íÇÑ °ÍÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ´Â ¿Â¶óÀÎ ºÎ¹®

ÀüÀÚ»ó°Å·¡ Ç÷§ÆûÀÇ ÀαⰡ ³ô¾ÆÁö°í ¿Â¶óÀÎ ¼îÇÎÀÇ ÆíÀǼºÀ¸·Î ÀÎÇØ ¿Â¶óÀÎ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Äڷγª19ÀÇ À¯ÇàÀº ÀÌ µ¿ÇâÀ» °¡¼ÓÈ­½ÃÄÑ ´õ ¸¹Àº ¼ÒºñÀÚµéÀÌ °Ç°­ °ü·Ã Á¦Ç°À» ¿Â¶óÀΠä³Î¿¡¼­ ã°Ô µÇ°í ÀÖ½À´Ï´Ù. ¿Â¶óÀÎ Ç÷§ÆûÀº ´Ù¾çÇÑ Ã¼¿Â ¸ð´ÏÅ͸µ Àåºñ, °æÀï °¡°Ý, ÅÃ¹è ÆíÀǼºÀ» Á¦°øÇÕ´Ï´Ù. Á¦Ç° ºñ±³, ±¸¸Å Èı⠺¸±â, »ó¼¼ÇÑ Á¦Ç° Á¤º¸¿¡ ´ëÇÑ ¾×¼¼½º¸¦ ¿Â¶óÀÎÀ¸·Î ½±°Ô ÇÒ ¼ö ÀÖ´Â °Íµµ ÀÌ ¼¼±×¸ÕÆ®ÀÇ ±Þ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª :

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¿ìÀ§¼ºÀº ÀÌ Áö¿ªÀÇ Ã·´Ü ÇコÄɾî ÀÎÇÁ¶ó, °í¾×ÀÇ ÀÇ·áºñ, Çõ½ÅÀûÀÎ ÀÇ·á ±â¼úÀÇ Á¶±â µµÀÔ¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, Á¦Ç°ÀÇ Ç°ÁúÀ» º¸ÀåÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ, ¼ÒºñÀÚÀÇ °Ç°­ ÀÇ½Ä Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâÀ¸·Î °Ç°­ °ü¸®, Á÷Àå, °ø°ø Àå¼Ò µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ü¿Â ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Ã¤¿ëÀÌ ´õ¿í °¡¼ÓÈ­µÇ¾î ü¿Â ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ ÁÖ¿ä ½ÃÀåÀ¸·Î ºÏ¹ÌÀÇ ÁöÀ§°¡ È®°íÇØÁö°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ´Þ¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ±Þ¼ºÀåÀº Àα¸ÀÇ ¸¹°í ÀûÀ½, ÇコÄɾî ÁöÃâÀÇ Áõ°¡, ¿¹¹æ ÇコÄɾ ´ëÇÑ ÀǽÄÀÇ °íÁ¶ µîÀÇ ¿äÀο¡ ÀÇÇÑ °ÍÀÔ´Ï´Ù. ÀÌ Áö¿ª ½ÅÈï±¹Àº ±Þ¼ÓÇÑ µµ½ÃÈ­ ¹× Çコ Äɾî ÀÎÇÁ¶óÀÇ °³¼±À» ¸ñ°ÝÇϰí ÀÖÀ¸¸ç, ¼±Áø ÀÇ·á±â±âÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ Äڷγª19 ÆÒµ¥¹ÍÀº °øÁߺ¸°Ç °ü¸®¿¡ À־ ü¿Â ¸ð´ÏÅ͸µÀÇ Á߿伺À» ³ô¿© ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃã ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå Ãß°è, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¿¡ ±â¹ÝÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ±â¼ú ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : µð¹ÙÀ̽º À¯Çüº°

  • ¿þ¾î·¯ºí µð¹ÙÀ̽º
    • ½º¸¶Æ® ¿öÄ¡
    • ÇÇÆ®´Ï½º ¹êµå
    • ¼¾¼­ ÆÐÄ¡
    • ½º¸¶Æ®ÇÑ ¿Ê
  • ºñ¿þ¾î·¯ºí µð¹ÙÀ̽º
    • ÇÚµåÇïµå ¿Âµµ°è
    • À̸¶ ¿Âµµ°è
    • ±Í¿ë ü¿Â°è
    • ¿Âµµ ½ºÆ®¸³
    • ±âŸ ºñ¿þ¾î·¯ºí µð¹ÙÀ̽º

Á¦6Àå ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ÃøÁ¤ ¹æ¹ýº°

  • Á¢Ã˺£À̽º
    • ±¸°­
    • Á÷Àå
    • ¾×¿Í(°Üµå¶ûÀÌ ¹Ø)
    • °í½Ç(±Í)
  • ºñÁ¢ÃË
    • À̸¶ ½ºÄµ
    • ¸®¸ðÆ® ¼¾½Ì

Á¦7Àå ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ±â¼úº°

  • µðÁöÅÐ ÀüÀÚ
  • Àû¿Ü¼± °¨Áö
  • Á¾·¡ÀÇ ¹æ¹ý
    • ¼öÀº
    • ¾×Á¤ µð½ºÇ÷¹ÀÌ
  • ¿­Àü´ë
  • ¼­¹Ì½ºÅÍ
  • ¿­È­»ó

Á¦8Àå ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¹× Áø·á¼Ò
  • ÀçÅà ÇコÄɾî
  • ½ºÆ÷Ã÷ ¹× À°»ó °æ±â
  • Á÷Àå ¹× »ê¾÷
  • ±âŸ ÃÖÁ¾ »ç¿ëÀÚ

Á¦9Àå ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : À¯Åë ä³Îº°

  • ¿Â¶óÀÎ
    • ÀüÀÚ»ó°Å·¡ Ç÷§Æû
    • ±â¾÷ À¥»çÀÌÆ®
  • ¿ÀÇÁ¶óÀÎ
    • ¼Ò¸Å ¾à±¹
    • º´¿ø ¾à±¹

Á¦10Àå ¼¼°èÀÇ Ã¼¿Â ¸ð´ÏÅ͸µ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛ ÅõÀÚ
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • 3M Company
  • Omron Corporation
  • Welch Allyn
  • Cardinal Health, Inc.
  • Koninklijke Philips NV
  • Dragerwerk AG & Co. KGaA
  • Terumo Corporation
  • Microlife Corporation
  • American Diagnostic Corporation
  • Braun GmbH
  • Easywell Biomedicals, Inc.
  • Exergen Corporation
  • Geratherm Medical AG
  • Helen of Troy Limited
  • Masimo Corporation
  • Medtronic plc
  • Cosinuss GmbH
  • A&D Company, Limited
AJY 24.11.18

According to Stratistics MRC, the Global Body Temperature Monitoring Market is accounted for $1.7 billion in 2024 and is expected to reach $2.4 billion by 2030, growing at a CAGR of 6.3% during the forecast period. The process of taking a person's body temperature and tracking it in order to identify any anomalies-like fever or hypothermia-that may point to health problems is known as body temperature monitoring. Because it makes early infection diagnosis and chronic condition monitoring possible, it is an essential component of healthcare. Thermometers are used in a variety of contexts, such as homes, sports, and hospitals. As a result of ongoing technological developments, temperature monitoring solutions have become more precise, practical, and real-time.

According to the Centers for Disease Control and Prevention (CDC), during the 2022-2023 flu seasons in the United States there were an estimated 27-54 million flu illnesses.

Market Dynamics:

Driver:

Growing prevalence of infectious diseases

The increasing prevalence of infectious diseases like influenza, COVID-19, and other viral infections is driving the demand for body temperature monitoring devices. Fever is a common symptom of many infectious diseases. Accurate temperature measurement becomes crucial for early detection and monitoring of illness progression. This has led to a surge in the adoption of temperature monitoring solutions in healthcare settings, public spaces, and homes. The need for continuous temperature tracking during disease outbreaks has further accelerated market growth, prompting innovations in wearable and non-contact temperature monitoring technologies.

Restraint:

Accuracy concerns in wearables

While wearable technologies offer convenience and continuous monitoring capabilities, their accuracy can be affected by factors such as environmental conditions, skin contact, and individual physiological variations. This can lead to inconsistent or unreliable temperature readings, potentially compromising clinical decision-making and patient care. Healthcare professionals and consumers may hesitate to fully rely on wearable temperature monitors, preferring traditional methods for critical temperature assessments.

Opportunity:

Increasing emphasis on preventive healthcare

Individuals are becoming more health-conscious and proactive about managing their well-being. Due to this, the demand for personal health monitoring devices, including temperature sensors, is rising. This trend is further supported by the integration of temperature monitoring features in smartwatches and fitness trackers, making it easier for consumers to track their body temperature regularly. Additionally, healthcare providers are increasingly emphasizing early detection and prevention of illnesses, driving the adoption of advanced temperature monitoring solutions in clinical settings for continuous patient monitoring and early intervention.

Threat:

Data privacy

These monitoring devices gather sensitive information about an individual's body temperature and potentially other health metrics. There are growing concerns about data security, unauthorized access, and potential misuse of this information. Strict data protection regulations and the need for robust cybersecurity measures can increase development costs and complexity for manufacturers. Moreover, consumer apprehension about data privacy may hinder the adoption of advanced temperature monitoring solutions, especially in non-clinical settings, potentially limiting market growth.

Covid-19 Impact:

The COVID-19 pandemic significantly boosted the body temperature monitoring market. Widespread temperature screening became essential in healthcare facilities, workplaces, and public spaces to detect potential infections. This led to increased demand for non-contact thermometers and thermal imaging systems. The pandemic also accelerated innovations in wearable temperature monitoring devices and remote patient monitoring solutions, reshaping market trends and consumer preferences.

The contact-based segment is expected to be the largest during the forecast period

The contact-based segment is predicted to secure the largest market share throughout the forecast period. This dominance is attributed to the widespread use of contact thermometers in healthcare settings and homes due to their perceived accuracy and reliability. Contact-based devices are preferred for their precision in clinical diagnoses and patient care. The familiarity and trust in these traditional methods, coupled with their cost-effectiveness and ease of use, contribute to their continued popularity and solidify their position in the market.

The online segment is expected to have the highest CAGR during the forecast period

The online segment is projected to witness substantial growth during the projection period, driven by the increasing popularity of e-commerce platforms and the convenience of online shopping. The COVID-19 pandemic has accelerated this trend, with more consumers turning to online channels for health-related products. Online platforms offer a wide variety of temperature monitoring devices, competitive pricing, and the convenience of home delivery. The ease of comparing products, reading customer reviews, and accessing detailed product information online contributes to the segment's rapid growth.

Region with largest share:

The North America region is projected to account for the largest market share during the forecast period. This dominance is attributed to the region's advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. The presence of major market players, stringent regulatory standards ensuring product quality, and increased health awareness among consumers contribute to the market's growth. Additionally, the impact of the COVID-19 pandemic has further accelerated the adoption of temperature monitoring solutions in various sectors, including healthcare, workplaces, and public spaces, solidifying North America's position as the leading market for body temperature monitoring devices.

Region with highest CAGR:

The Asia Pacific region is projected to achieve the highest CAGR during the forecast period. This rapid growth is driven by factors such as the large population base, increasing healthcare expenditure, and growing awareness about preventive healthcare. The region's emerging economies are witnessing rapid urbanization and improvements in healthcare infrastructure, leading to increased adoption of advanced medical devices. Additionally, the COVID-19 pandemic has heightened the importance of temperature monitoring in public health management, further boosting market growth.

Key players in the market

Some of the key players in Body Temperature Monitoring Market include 3M Company, Omron Corporation, Welch Allyn, Cardinal Health, Inc., Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Terumo Corporation, Microlife Corporation, American Diagnostic Corporation, Braun GmbH, Easywell Biomedicals, Inc., Exergen Corporation, Geratherm Medical AG, Helen of Troy Limited, Masimo Corporation, Medtronic plc, Cosinuss GmbH, and A&D Company, Limited.

Key Developments:

In April 2024, Royal Philips, a global leader in health technology, announced a strategic partnership to integrate smartQare's advanced solution, viQtor, with Philips' world-leading clinical patient monitoring platforms. This collaboration aims to enable the next generation of continuous patient monitoring both in and out of the hospital, starting in Europe.

In September 2023, Welch Allyn, a leading medical diagnostic device company that is now part of Hill-Rom, has introduced a new electronic ear thermometer that offers advanced measurement technology to help capture accurate, reliable temperature readings. The Welch Allyn Braun ThermoScan(R) PRO 6000 Ear Thermometer with exclusive PerfecTemp(TM) technology helps overcome challenges presented by ear canal anatomy and variability in probe placement. The thermometer collects information about the direction and depth of ear probe placement and automatically incorporates it into temperature calculation-helping to increase the accuracy of readings.

Device Types Covered:

  • Wearable Devices
  • Non-Wearable Devices

Measurement Methods Covered:

  • Contact-based
  • Non-contact

Technologies Covered:

  • Digital Electronic
  • Infrared Sensing
  • Traditional Methods
  • Thermocouple
  • Thermistor
  • Thermal Imaging

End Users Covered:

  • Hospitals and Clinics
  • Home Healthcare
  • Sports and Athletics
  • Workplaces and Industries
  • Other End Users

Distribution Channels Covered:

  • Online
  • Offline

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Body Temperature Monitoring Market, By Device Type

  • 5.1 Introduction
  • 5.2 Wearable Devices
    • 5.2.1 Smartwatches
    • 5.2.2 Fitness Bands
    • 5.2.3 Sensor Patches
    • 5.2.4 Smart Clothing
  • 5.3 Non-Wearable Devices
    • 5.3.1 Handheld Thermometers
    • 5.3.2 Forehead Thermometers
    • 5.3.3 Ear Thermometers
    • 5.3.4 Temperature Strips
    • 5.3.5 Other Non-Wearable Devices

6 Global Body Temperature Monitoring Market, By Measurement Method

  • 6.1 Introduction
  • 6.2 Contact-based
    • 6.2.1 Oral
    • 6.2.2 Rectal
    • 6.2.3 Axillary (Armpit)
    • 6.2.4 Tympanic (Ear)
  • 6.3 Non-contact
    • 6.3.1 Forehead Scan
    • 6.3.2 Remote Sensing

7 Global Body Temperature Monitoring Market, By Technology

  • 7.1 Introduction
  • 7.2 Digital Electronic
  • 7.3 Infrared Sensing
  • 7.4 Traditional Methods
    • 7.4.1 Mercury Expansion
    • 7.4.2 Liquid Crystal Display
  • 7.5 Thermocouple
  • 7.6 Thermistor
  • 7.7 Thermal Imaging

8 Global Body Temperature Monitoring Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals and Clinics
  • 8.3 Home Healthcare
  • 8.4 Sports and Athletics
  • 8.5 Workplaces and Industries
  • 8.6 Other End Users

9 Global Body Temperature Monitoring Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Online
    • 9.2.1 E-Commerce Platforms
    • 9.2.2 Company Websites
  • 9.3 Offline
    • 9.3.1 Retail Pharmacies
    • 9.3.2 Hospital Pharmacies

10 Global Body Temperature Monitoring Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 3M Company
  • 12.2 Omron Corporation
  • 12.3 Welch Allyn
  • 12.4 Cardinal Health, Inc.
  • 12.5 Koninklijke Philips N.V.
  • 12.6 Dragerwerk AG & Co. KGaA
  • 12.7 Terumo Corporation
  • 12.8 Microlife Corporation
  • 12.9 American Diagnostic Corporation
  • 12.10 Braun GmbH
  • 12.11 Easywell Biomedicals, Inc.
  • 12.12 Exergen Corporation
  • 12.13 Geratherm Medical AG
  • 12.14 Helen of Troy Limited
  • 12.15 Masimo Corporation
  • 12.16 Medtronic plc
  • 12.17 Cosinuss GmbH
  • 12.18 A&D Company, Limited
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦